Zurcher Kantonalbank (Zurich Cantonalbank) Lexicon Pharmaceuticals, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

  • $32.8 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023
SELL
$1.99 - $2.68 $31,229 - $42,057
-15,693 Reduced 43.02%
20,787 $50,000
Q4 2022

Feb 01, 2023
BUY
$1.8 - $2.56 $42,825 - $60,907
23,792 Added 187.52%
36,480 $69,000
Q4 2021

Feb 01, 2022
BUY
$3.81 - $6.16 $48,341 - $78,158
12,688 New
12,688 $50,000
Q2 2020

Jul 28, 2020
SELL
$1.75 - $2.3 $7,372 - $9,689
-4,213 Closed
0 $0
Q1 2018

May 03, 2018
BUY
$7.86 - $11.39 $22,605 - $32,757
2,876 Added 215.11%
4,213 $36,000
Q3 2017

Nov 08, 2017
BUY
$12.17 - $16.3 $16,271 - $21,793
1,337
1,337 $16,000

Others Institutions Holding LXRX

# of Institutions
141
Shares Held
238M
Call Options Held
459K
Put Options Held
133K
View Full List

About LEXICON PHARMACEUTICALS, INC.

LXRX Quotes by TradingView
  • Ticker LXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,726,000
  • Market Cap $134M
  • Description
  • Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...
More about LXRX
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email